Balyasny Asset Management’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-266,005
| Closed | -$1.72M | – | 2510 |
|
|
2025
Q1 | $1.72M | Buy |
266,005
+209,221
| +368% | +$1.36M | ﹤0.01% | 1200 |
|
|
2024
Q4 | $417K | Buy |
56,784
+30,351
| +115% | +$223K | ﹤0.01% | 1529 |
|
|
2024
Q3 | $198K | Buy |
+26,433
| New | +$198K | ﹤0.01% | 1797 |
|
|
2023
Q4 | – | Sell |
-235,604
| Closed | -$2.21M | – | 2304 |
|
|
2023
Q3 | $2.21M | Sell |
235,604
-283,248
| -55% | -$2.65M | ﹤0.01% | 978 |
|
|
2023
Q2 | $12.7M | Buy |
518,852
+115,904
| +29% | +$2.84M | 0.03% | 538 |
|
|
2023
Q1 | $9.38M | Buy |
+402,948
| New | +$9.38M | 0.02% | 620 |
|
|
2022
Q4 | – | Sell |
-385,146
| Closed | -$7.43M | – | 2775 |
|
|
2022
Q3 | $7.43M | Buy |
385,146
+374,897
| +3,658% | +$7.23M | 0.02% | 642 |
|
|
2022
Q2 | $261K | Buy |
+10,249
| New | +$261K | ﹤0.01% | 1706 |
|
|
2022
Q1 | – | Sell |
-218,710
| Closed | -$9.16M | – | 2528 |
|
|
2021
Q4 | $9.16M | Buy |
218,710
+191,899
| +716% | +$8.03M | 0.03% | 559 |
|
|
2021
Q3 | $1.17M | Buy |
26,811
+7,468
| +39% | +$325K | ﹤0.01% | 1078 |
|
|
2021
Q2 | $915K | Buy |
+19,343
| New | +$915K | ﹤0.01% | 1154 |
|
|
2020
Q2 | – | Sell |
-91,977
| Closed | -$3.15M | – | 1337 |
|
|
2020
Q1 | $3.15M | Buy |
+91,977
| New | +$3.15M | 0.04% | 441 |
|